Biotech Medics Ne Stock Current Valuation
| BMCS Stock | USD 0.01 0 12.41% |
Valuation analysis of Biotech Medics Ne helps investors to measure Biotech Medics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Biotech Medics' price fluctuation is out of control at this time. Calculation of the real value of Biotech Medics Ne is based on 3 months time horizon. Increasing Biotech Medics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biotech pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Biotech Medics Ne. Since Biotech Medics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotech Pink Sheet. However, Biotech Medics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.012 | Real 0.008967 | Hype 0.01 | Naive 0.0133 |
The intrinsic value of Biotech Medics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotech Medics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotech Medics Ne helps investors to forecast how Biotech pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotech Medics more accurately as focusing exclusively on Biotech Medics' fundamentals will not take into account other important factors: Biotech Medics Ne Company Current Valuation Analysis
Biotech Medics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biotech Medics Current Valuation | 9.68 M |
Most of Biotech Medics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Medics Ne is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Biotech Medics Ne has a Current Valuation of 9.68 M. This is 99.93% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Biotech Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Medics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotech Medics could also be used in its relative valuation, which is a method of valuing Biotech Medics by comparing valuation metrics of similar companies.Biotech Medics is currently under evaluation in current valuation category among its peers.
Biotech Fundamentals
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 172.36 M | |||
| Price To Earning | (0.47) X | |||
| Price To Sales | 3.30 X | |||
| Revenue | 469.8 K | |||
| Gross Profit | 408.14 K | |||
| EBITDA | 33.35 K | |||
| Net Income | (603.72 K) | |||
| Cash And Equivalents | 1.31 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | 0.02 X | |||
| Earnings Per Share | (0) X | |||
| Beta | 3.5 | |||
| Market Capitalization | 870.4 K | |||
| Total Asset | 5.08 M | |||
| Retained Earnings | (1.75 M) | |||
| Working Capital | (1.98 M) | |||
| Current Asset | 27 K | |||
| Current Liabilities | 2.01 M | |||
| Net Asset | 5.08 M |
About Biotech Medics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Medics Ne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Medics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Medics Ne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.